Copyright
©The Author(s) 2023.
World J Clin Cases. Apr 26, 2023; 11(12): 2694-2707
Published online Apr 26, 2023. doi: 10.12998/wjcc.v11.i12.2694
Published online Apr 26, 2023. doi: 10.12998/wjcc.v11.i12.2694
Data source | Case | Age, yr | Sex | Clinical symptoms | |||||||
Headache | Vision loss | Visual field | OP | DI | HT | CS | Acromegaly | ||||
Peking Union Medical College Hospital | 1 | 29 | F | No | Bi | BTH | No | No | No | No | No |
2 | 36 | F | Yes | Bi | BTH | No | No | No | No | No | |
3 | 34 | F | No | Bi | BTH | Yes | Yes | No | No | No | |
4 | 32 | F | No | No | No | No | No | Yes | No | No | |
5 | 37 | F | Yes | Mo | BTH | No | No | No | No | No | |
6 | 28 | F | Yes | Bi | BTH | No | No | No | No | No | |
Jallad et al[16] | 7 | 25 | F | Yes | No | BTH | No | No | No | No | Yes |
8 | 27 | F | Yes | No | BTH | No | No | No | No | Yes | |
9 | 27 | F | Yes | No | BTH | No | No | No | No | Yes | |
Chaiamnuay et al[17] | 10 | 39 | F | Yes | No | UTH | No | No | Yes | No | No |
Guven et al[18] | 11 | 32 | F | No | Bi | BTH | No | No | No | No | Yes |
Zhong et al[38] | 12 | 29 | F | No | Bi | No | No | No | No | No | No |
Jemel et al[19] | 13 | 35 | F | Yes | No | BTH | No | No | No | No | No |
14 | 30 | F | Yes | Bi | BTH | No | No | No | No | No | |
Xia et al[20] | 15 | 25 | F | Yes | Bi | BTH | No | No | No | No | No |
Yamaguchi et al[21] | 16 | 35 | F | Yes | Bi | UTH | No | No | No | No | No |
Tandon et al[22] | 17 | 27 | F | Yes | Mo | BTH | No | No | No | No | No |
Parihar et al[36] | 18 | 22 | F | Yes | Bi | No | No | No | No | No | No |
Gondim et al[23] | 19 | 29 | F | Yes | Mo | UTH | Yes | No | No | No | No |
Witek et al[24] | 20 | 25 | F | Yes | Bi | BTH | No | No | No | No | No |
Kita et al[25] | 21 | 26 | F | Yes | No | BTH | No | No | No | No | No |
Nossek et al[26] | 22 | 29 | F | No | Bi | No | No | No | No | No | No |
23 | 34 | F | No | No | BTH | No | No | No | No | No | |
Iuliano and Laws[27] | 24 | 28 | F | Yes | No | No | No | No | No | No | No |
25 | 35 | F | Yes | Mo | UTH | Yes | No | No | No | No | |
Hayes et al[28] | 26 | 41 | F | Yes | No | BTH | No | No | No | No | No |
Boronat et al[52] | 27 | 26 | F | No | No | No | No | No | No | Yes | No |
Abbassy et al[37] | 28 | 38 | F | Yes | No | No | No | No | No | Yes | No |
Coyne et al[53] | 29 | 22 | F | No | No | No | No | No | No | Yes | No |
Pinette et al[54] | 30 | 33 | F | No | No | No | No | No | No | Yes | No |
Ross et al[55] | 31 | 24 | F | No | No | No | No | No | No | Yes | No |
Mellor et al[51] | 32 | 40 | F | No | No | No | No | No | No | Yes | No |
Karaca et al[15] | 33 | NA | F | No | No | No | Yes | No | No | No | Yes |
Jolly et al[56] | 34 | 30 | F | No | No | No | No | No | No | Yes | No |
Galvão et al[29] | 35 | NA | F | Yes | Bi | BTH | No | No | No | No | No |
Abid et al[30] | 36 | 25 | F | Yes | Bi | BTH | No | No | No | No | No |
Barraud et al[31] | 37 | NA | F | Yes | No | BTH | No | No | No | No | No |
Freeman et al[32] | 38 | 22 | F | Yes | Mo | BTH | No | Yes | No | No | No |
Lunardi et al[33] | 39 | 21 | F | Yes | Bi | BTH | No | No | No | No | Yes |
Oguz et al[34] | 40 | 26 | F | Yes | No | UTH | No | No | No | No | No |
O’Neal[35] | 41 | 27 | F | Yes | No | BTH | No | No | No | No | No |
Ref. | Case | Treatment | Pathology | Follow up | ||||
Medical therapy | Operation | Delivery | M | I | ||||
Pre | Post | |||||||
Peking Union Medical College Hospital | 1 | Bromocriptine | No | 12th W TSS | 40th W CS | NF PA | ER | H |
2 | No | No | 32nd W TSS | Full term CS | NF PA | ER | H | |
3 | No | No | 22nd W TSS | 38th W CS | NF PA | ER | H | |
4 | Sandostatin | No | 26th W TSS | 38th W CS | TSH PA | ER | H | |
5 | Bromocriptine | No | 35th W TSS | 35th W CS | PRL PA | ER | H | |
6 | Prednisone, thyroxine | Prednisone, thyroxine | 30th W TSS | 39th W CS | NF PA | ER | H | |
Jallad et al[16] | 7 | No | No | 3rd Mon TSS | 38thW CS | GH PA | ER | H |
8 | No | No | 4th Mon TSS | 16th W A | GH PA | EC | A | |
9 | Cabergoline | No | 4th Mon TSS | 39th W CS | GH PA | ER | H | |
Chaiamnuay et al[17] | 10 | Propylthiouracil, bromocriptine | No | 27th W TSS | 39th W CS | TSH PA | ER | H |
Guven et al[18] | 11 | No | Octreotide | 34th W TSS | 34th W CS | GH PA | EC | H |
Zhong et al[38] | 12 | No | Cortisone, thyroxine | 22nd W TSS | 40th W VD | NF PA | ER | H |
Jemel et al[19] | 13 | Cabergoline, hydrocortisone | No | 22nd W TSS | 37th W VD | NF PA | ER | H |
14 | Corticosteroids | No | 24th W TSS | 38th W VD | NF PA | ER | H | |
Xia et al[20] | 15 | No | No | 24th W TSS | 38th W CS | PRL PA | ER | H |
Yamaguchi et al[21] | 16 | No | Methyl prednisolone | 36th W TSS | 37th W CS | PRL PA, Optic neuritis | ER | H |
Tandon et al[22] | 17 | Bromocriptine | Desmopressin | 36th W TSS | 37th W CS | PRL PA | ER | H |
Parihar et al[36] | 18 | No | No | 20th W TSS | Full term VD | PRL PA | ER | H |
Gondim et al[23] | 19 | Bromocriptine | Thyroxine, hydrocortisone | 32nd W TSS | 39th W VD | PRL PA | EC | H |
Witek et al[24] | 20 | Bromocriptine | Hydrocortisone | 20th W TSS | 38th W CS | PRL PA | ER | H |
Kita et al[25] | 21 | No | DDAVP | 27th W TSS | 40th W VD | NF PA | ER | H |
Nossek et al[26] | 22 | No | No | 33rd W TSS | 35th W CS | PA | ER | LAS |
23 | No | No | 31st W TSS | 40th W VD | PA | ER | H | |
Iuliano and Laws[27] | 24 | Bromocriptine, dexamethasone | No | 30th W TSS | 39th W CS | NF PA | ER | H |
25 | Bromocriptine, dexamethasone | Levothyroxine, hydrocortisone | 33rd W TSS | 39th W CS | NF PA | ER | H | |
Hayes et al[28] | 26 | Corticosteroids | No | 18th W TSS | Full term VD | PRL PA | ER | H |
Boronat et al[52] | 27 | Alpha-metildopa | Metyrapone | 16th W TSS | 34th W VD | ACTH PA | R | H |
Abbassy et al[37] | 28 | No | Hydrocortisone, desmopressin | 18th W TSS | 39th W VD | ACTH PA | ER | H |
Coyne et al[53] | 29 | No | Hydrocortisone, desmopressin | 14th W TSS | 38th W VD | ACTH PA | ER | H |
Pinette et al[54] | 30 | No | Atenolol | 16th W TSS | - | ACTH PA | ER | D |
Ross et al[55] | 31 | No | Dexamethasone | 18th W TSS | 37th W CS | ACTH PA | ER | H |
Mellor et al[51] | 32 | No | Hydrocortisone | Mid-trimester TSS | 34th W CS | ACTH PA | ER | H |
Karaca et al[15] | 33 | No | No | 11th W TSS | 39th W CS | GH PA | ER | H |
Jolly et al[56] | 34 | No | Hydrocortisone, metformin, labetalol, nifedipine | 23rd W TSS | 38th W CS | ACTH PA | ER | D |
Galvão et al[29] | 35 | No | No | 2nd trimester TSS | - | PRL PA | ER | H |
Abid et al[30] | 36 | Bromocriptine | Lisuride hydrogen | 27th W TSS | 39th W VD | PRL PA | ER | H |
Barraud et al[31] | 37 | Bromocriptine | No | 4th Mon TSS | - | PRL PA | ER | H |
Freeman et al[32] | 38 | DDAVP | Hydrocortisone, thyroxine, DDAVP | 32nd W TSS | 39th W VD | PRL PA | ER | H |
Lunardi et al[33] | 39 | No | No | 6th Mon TSS | Full term VD | GH PA | EC | H |
Oguz et al[34] | 40 | No | Levothyroxine | 23rd W TSS | 37th W CS | PRL PA | ER | H |
O’Neal[35] | 41 | Hydrocortisone, bromocriptine | No | 29th W TSS | 37th W VD | PA | ER | H |
- Citation: Jia XY, Guo XP, Yao Y, Deng K, Lian W, Xing B. Surgical management of pituitary adenoma during pregnancy. World J Clin Cases 2023; 11(12): 2694-2707
- URL: https://www.wjgnet.com/2307-8960/full/v11/i12/2694.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i12.2694